Mean change in Δ1/T1 using oxygen and carbogen inhalation.

Title
DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents
Authors
J P B O'Connor, A Jackson, G J M Parker and G C Jayson
Journal
Brit. J. Cancer
Link
http://www.nature.com/bjc/journal/v96/n2/abs/6603515a.html
Year
2007
Volume
96
Pages
189–95
Month
January
Abstract
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is now frequently used in early clinical trial assessment of antiangiogenic and vascular disrupting compounds. Evidence of drug efficacy and dose-dependent response has been demonstrated with some angiogenesis inhibitors. This review highlights the critical issues that influence T1-weighted DCE-MRI data acquisition and analysis, identifies important areas for future development and reviews the clinical trial findings to date.